Amgen Inc. - Common Stock (AMGN) stock analysis

AMGN · Amgen Inc. - Common Stock

Latest recorded price: USD 462.32

Model-estimated fair value: USD 427.62. This assumption-based estimate is for general research and is not investment advice.

Sector and industry: Healthcare · Drug Manufacturers - General

At $462.32, AMGN trades 8.1% above the model's base-case value of $427.62. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $317.32 in the conservative case and $555.16 in the optimistic case, with a valuation confidence score of 75/100. About 74% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 11.8%, free cash flow margin 22.0%, ROIC 14.5%. The model flags 1 risk signal for this company.

Similar companies in Healthcare